Namin AW, et al. - Authors evaluated the survival outcomes in candidates who underwent retreatment of recurrent cutaneous melanoma of the head and neck between January 1, 2000, and December 31, 2015. Development of recurrence was observed in 33 cases. At last follow-up, they found 66% of candidates who developed local recurrence first and 50% of cases who developed regional recurrence first were alive without evidence (NED) of disease. Whereas no participant among cases who developed distant or simultaneous recurrences first was NED at last follow-up. The meantime from recurrence to the last follow-up was 735 days among the 7 subjects who were NED. They noted that 58% of subjects with isolated local or regional recurrences obtained durable curative treatment for recurrent melanoma.